Drugs / Tangwang prescription
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03025399 | Feb 2017 → May 2019 | diabetic retinopathy, type 2 diabetes mellitus | Fengmei Lian | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tangwang prescription | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03025399 ↗ |
| Known as | TWP | “TangWang prescription (TWP) has been found to have retinal protection effects in previous clinical and basic research.” PMID 33790783 ↗ Mar 2021 |
| Modality | Traditional medicine (herbal / TCM) | “A kind of Granule(Tangwang prescription) was composition by five Chinese herbal medicines” NCT03025399 ↗ |
| Route | Oral | “take it one bag each time, two times a day” NCT03025399 ↗ |